Your browser doesn't support javascript.
loading
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
Tamura, Tomokazu; Yamasoba, Daichi; Oda, Yoshitaka; Ito, Jumpei; Kamasaki, Tomoko; Nao, Naganori; Hashimoto, Rina; Fujioka, Yoichiro; Suzuki, Rigel; Wang, Lei; Ito, Hayato; Kashima, Yukie; Kimura, Izumi; Kishimoto, Mai; Tsuda, Masumi; Sawa, Hirofumi; Yoshimatsu, Kumiko; Yamamoto, Yuki; Nagamoto, Tetsuharu; Kanamune, Jun; Suzuki, Yutaka; Ohba, Yusuke; Yokota, Isao; Matsuno, Keita; Takayama, Kazuo; Tanaka, Shinya; Sato, Kei; Fukuhara, Takasuke.
Afiliação
  • Tamura T; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamasoba D; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Oda Y; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ito J; Faculty of Medicine, Kobe University, Kobe, Japan.
  • Kamasaki T; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Nao N; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Hashimoto R; Department of Cell Physiology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Fujioka Y; Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan.
  • Suzuki R; AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.
  • Wang L; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Ito H; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Kashima Y; One Health Research Center, Hokkaido University, Sapporo, Japan.
  • Kimura I; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Kishimoto M; Department of Cell Physiology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Tsuda M; Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan.
  • Sawa H; AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.
  • Yoshimatsu K; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamamoto Y; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Nagamoto T; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Kanamune J; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Suzuki Y; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Ohba Y; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
  • Yokota I; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Matsuno K; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Takayama K; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Tanaka S; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Sato K; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Fukuhara T; One Health Research Center, Hokkaido University, Sapporo, Japan.
Commun Biol ; 6(1): 772, 2023 07 24.
Article em En | MEDLINE | ID: mdl-37488344

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Commun Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Commun Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão